Intracellular signaling pathways modulated by phenolic compounds: application for new anti-inflammatory drugs

G Costa1, V Francisco, M C Lopes

  • 1Faculdade de Farmácia, Universidade de Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.

Insights

Phenolic compounds from natural products show potential as anti-inflammatory agents by modulating key signaling pathways. Their structure-activity relationships offer a promising avenue for developing new, safer anti-inflammatory drugs.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Chronic inflammation underlies many diseases, including cancer and cardiovascular conditions.
  • Current anti-inflammatory drugs have limitations, necessitating novel therapeutic approaches.
  • Natural products, particularly phenolic compounds, offer a rich source of anti-inflammatory agents.

Purpose of the Study:

  • To review the anti-inflammatory effects of phenolic compounds.
  • To summarize the impact of phenols on various inflammation-associated signaling pathways.
  • To highlight the role of structure-activity relationships in developing new anti-inflammatory drugs.

Main Methods:

  • Literature review focusing on phenolic compounds and inflammation.
  • Analysis of studies investigating signaling pathways modulated by phenols.
  • Examination of the link between phenolic structure and anti-inflammatory activity.

Main Results:

  • Phenols modulate critical signaling pathways like NF-κB, AP-1, PPAR, Nrf2, MAPKs, PTKs, PI3K/Akt, and the ubiquitin-proteasome system.
  • These modulations lead to reduced production of inflammatory mediators (cytokines, iNOS, COX-2).
  • Structure-activity relationship studies provide insights into designing effective phenolic-based anti-inflammatory drugs.

Conclusions:

  • Phenolic compounds are potent modulators of inflammatory signaling pathways.
  • Their diverse mechanisms offer a basis for developing novel anti-inflammatory therapeutics.
  • Understanding structure-activity relationships is key for optimizing natural product-derived anti-inflammatory drug discovery.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...